|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.85 USD | +0.42% |
|
-5.48% | +15.70% |
Company Valuation: Encompass Health Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 8,222 | 6,493 | 5,968 | 6,688 | 9,304 | 10,751 | - | - |
| Change | - | -21.03% | -8.08% | 12.06% | 39.12% | 15.55% | - | - |
| Enterprise Value (EV) 1 | 11,287 | 9,660 | 8,682 | 9,296 | 11,679 | 13,144 | 13,199 | 13,154 |
| Change | - | -14.42% | -10.12% | 7.08% | 25.63% | 12.55% | 0.42% | -0.34% |
| P/E ratio | 29x | 15.9x | 22.2x | 19.2x | 20.7x | 19.9x | 18.5x | 17.5x |
| PBR | 5.18x | 3.4x | - | 4.1x | 4.5x | 3.71x | 3.31x | 2.88x |
| PEG | - | 0.4x | -0.6x | 0.7x | 0.7x | 1x | 2.55x | 2.89x |
| Capitalization / Revenue | 1.77x | 1.27x | 1.37x | 1.39x | 1.73x | 1.81x | 1.67x | 1.55x |
| EV / Revenue | 2.43x | 1.89x | 2x | 1.94x | 2.17x | 2.22x | 2.05x | 1.89x |
| EV / EBITDA | 13.1x | 9.4x | 10.6x | 9.57x | 10.6x | 10.6x | 9.81x | 9.03x |
| EV / EBIT | 18.3x | 12.5x | 15.1x | 13.3x | 14.5x | 13.3x | 12.3x | 11.7x |
| EV / FCF | 36.6x | 51.7x | 61.6x | 34.7x | 32.4x | 25.2x | 25.4x | 15.8x |
| FCF Yield | 2.74% | 1.93% | 1.62% | 2.88% | 3.09% | 3.96% | 3.94% | 6.31% |
| Dividend per Share 2 | 1.12 | 1.12 | - | 0.6 | 0.64 | 0.72 | 0.7667 | 0.81 |
| Rate of return | 1.35% | 1.72% | - | 0.9% | 0.69% | 0.67% | 0.72% | 0.76% |
| EPS 2 | 2.85 | 4.11 | 2.7 | 3.47 | 4.46 | 5.38 | 5.77 | 6.12 |
| Distribution rate | 39.3% | 27.3% | - | 17.3% | 14.3% | 13.4% | 13.3% | 13.2% |
| Net sales 1 | 4,644 | 5,122 | 4,349 | 4,801 | 5,373 | 5,931 | 6,443 | 6,953 |
| EBITDA 1 | 860.3 | 1,028 | 819.3 | 971.1 | 1,104 | 1,246 | 1,346 | 1,457 |
| EBIT 1 | 617.3 | 771.4 | 575.7 | 697.2 | 804.1 | 986.9 | 1,069 | 1,126 |
| Net income 1 | 284.2 | 412.2 | 271 | 352 | 455.7 | 550.5 | 595.5 | 642.6 |
| Net Debt 1 | 3,065 | 3,167 | 2,714 | 2,608 | 2,375 | 2,393 | 2,448 | 2,403 |
| Reference price 2 | 82.69 | 65.26 | 59.81 | 66.72 | 92.35 | 106.85 | 106.85 | 106.85 |
| Nbr of stocks (in thousands) | 99,432 | 99,492 | 99,788 | 1,00,241 | 1,00,750 | 1,00,616 | - | - |
| Announcement Date | 26/01/21 | 01/02/22 | 07/02/23 | 07/02/24 | 06/02/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 19.78x | 2.21x | 10.51x | 0.68% | 1.07TCr | ||
| 38.18x | 3.36x | 14.99x | 1.21% | 1.8TCr | ||
| 28.98x | 4.45x | 15.45x | 1.45% | 1.48TCr | ||
| 53.64x | 4.2x | 28.53x | 0.31% | 1.12TCr | ||
| 29.5x | 2.29x | 19.53x | 0.14% | 998.38Cr | ||
| 18.51x | 2.77x | 11.21x | 3.95% | 958.85Cr | ||
| 15.79x | 1.35x | 9.29x | 1.17% | 825.82Cr | ||
| 56.4x | 7.15x | 30.66x | 0.16% | 716.41Cr | ||
| 26.16x | 0.82x | 6.8x | 2.44% | 542.76Cr | ||
| 39.35x | 5.16x | 24.68x | 0.27% | 419.74Cr | ||
| Average | 32.63x | 3.38x | 17.17x | 1.18% | 993.55Cr | |
| Weighted average by Cap. | 32.65x | 3.37x | 16.82x | 1.19% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- EHC Stock
- Valuation Encompass Health Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















